GenMAPP-CS, a dynamic resource pathway analysis
GenMAPP-CS,动态资源路径分析
基本信息
- 批准号:7470710
- 负责人:
- 金额:$ 40.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-18 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIM1 geneAnimal ModelAppendixArchitectureBioinformaticsBiologicalBiological ModelsBiological ProcessBiologyCell modelCellsCellular biologyChromosome MappingClientCommunitiesComplementComplexComputer softwareDNA Microarray ChipDNA Microarray formatDataData SetDatabasesDevelopmentDevelopment PlansDocumentationEngineered GeneEnvironmentExonsFaceFigs - dietaryFloodsFutureGenerationsGeneric DrugsGenesGenetic PolymorphismGenetic TranscriptionGenomeGenomicsGoalsGraphHandImageryInternetJavaLaboratoriesLinkMethodsModelingPathway AnalysisPathway interactionsPrincipal InvestigatorPublicationsRNA InterferenceRNA SplicingResearchResearch PersonnelResourcesSingle Nucleotide PolymorphismStandards of Weights and MeasuresSystemTertiary Protein StructureTimeTranscriptUpdateVariantWorkbasecomputer programdata modelingdesigndigitaldriving forcefile formatopen sourceprogramsprotein protein interactionresearch studysizetool
项目摘要
DESCRIPTION (provided by applicant): Pathway-oriented visualization of genomic information enables biologists to interpret data in the context of biological processes and systems. We developed GenMAPP (Gene Map Annotator and Pathway Profiler) as a free, open-source, stand-alone computer program for organizing, analyzing, and sharing genome-scale data in the context of biological pathways. This program is widely used for DMA microarray studies (>12,000 unique user registrations, >200 publications). Continuing demands of our users and the ever-increasing size and complexity of datasets now require a major revision of GenMAPP. We have formed key alliances with other open-source bioinformatics pathway projects whose efforts complement GenMAPP. We joined the Cytoscape (www.cytoscape.org) consortium as core developers so that we can build GenMAPP-CS using the advanced layout and visualization tools already available in Cytoscape. To facilitate pathway exchange, we are working closely with community-driven standards, (e.g. BioPAX and SBML) and several major public pathway databases (e.g., Reactome; www.reactome.org) to enhance pathway content and exchange. To implement this plan, we propose three specific aims. Specific Aim 1: To build GenMAPP-CS, a client-server version of GenMAPP, to provide a dynamic environment for visualizing and analyzing genomic data on biological pathways. GenMAPP-CS is being developed as an open-source, Java-based program to visualize and analyze datasets that exceed GenMAPP's current capabilities by 10-100-fold, while maintaining user interfaces and specific functions intuitive to biologists. Specific Aim 2: To dynamically integrate GenMAPP-CS with major gene and pathway databases for over 20 major model organisms. The new GenMAPP-CS architecture will allow us to integrate gene exon, single nucleotide polymorphism (SNP), and protein domain information with probe information at a scale that is impractical in GenMAPP 2.0. Specific Aim 3: To enable GenMAPP-CS to visualize and analyze genome-wide splicing, polymorphism, and interaction datasets. The challenge of analyzing these massive and complex datasets is a major force driving the development of GenMAPP-CS.
描述(由申请人提供):基因组信息的面向途径的可视化使生物学家能够在生物过程和系统的背景下解释数据。我们开发了Genmapp(基因图注释者和途径profiler)作为一种免费的,开源的,独立的计算机程序,用于在生物途径的背景下组织,分析和共享基因组规模数据。该程序广泛用于DMA微阵列研究(> 12,000个独特的用户注册,> 200个出版物)。现在,我们的用户的持续需求以及数据集的规模和复杂性不断增加,现在需要对GenMapp进行重大修订。我们已经与其他开源生物信息学途径项目建立了关键的联盟,他们的努力补充了Genmapp。我们加入了Cytoscape(www.cytoscape.org)联盟作为核心开发人员,因此我们可以使用Cytoscape中已经可用的高级布局和可视化工具来构建GenMapp-CS。为了促进路径交换,我们正在与社区驱动的标准(例如Biopax和SBML)以及几个主要的公共途径数据库(例如Reactome; www.reactome.org)紧密合作,以增强路径内容和交换。为了实施该计划,我们提出了三个具体目标。特定目的1:构建GenMapp-CS(genmapp的客户端版本),为可视化和分析生物途径的基因组数据提供了动态环境。 GenMapp-CS正在开发为基于Java的开源程序,以可视化和分析Genmapp当前功能的数据集,同时保持用户界面和对生物学家直观的特定功能。特定目的2:将GenMapp-C与主要基因和途径数据库动态整合,以适用于20多种主要模型生物。新的GenMAPP-CS结构将使我们能够整合基因外显子,单核苷酸多态性(SNP)和蛋白质结构域信息,并以探针信息的规模与Genmapp 2.0不切实际。特定目标3:使GenMapp-Cs能够可视化和分析全基因组剪接,多态性和相互作用数据集。分析这些庞大且复杂的数据集的挑战是推动GenMapp-CS发展的主要力量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce R Conklin其他文献
Dual α-globin and truncated EPO receptor knockin restores hemoglobin production in α-thalassemia-derived red blood cells
双 α-珠蛋白和截短的 EPO 受体敲入可恢复 α-地中海贫血来源的红细胞中血红蛋白的产生
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Simon N. Chu;E. Soupene;B. Wienert;Han Yin;Devesh Sharma;Travis McCreary;Kun Jia;Shota Homma;Jessica P. Hampton;James M. Gardner;Bruce R Conklin;T. Mackenzie;M. Porteus;M. Cromer - 通讯作者:
M. Cromer
Bruce R Conklin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce R Conklin', 18)}}的其他基金
C9orf72 frontotemporal dementia (FTD) and amyotrophic lateral sclerosis(ALS): using patient cells and CRISPR to reveal therapeutic approaches
C9orf72 额颞叶痴呆 (FTD) 和肌萎缩侧索硬化症 (ALS):利用患者细胞和 CRISPR 揭示治疗方法
- 批准号:
10590420 - 财政年份:2021
- 资助金额:
$ 40.11万 - 项目类别:
C9orf72 frontotemporal dementia (FTD) and amyotrophic lateral sclerosis(ALS): using patient cells and CRISPR to reveal therapeutic approaches
C9orf72 额颞叶痴呆 (FTD) 和肌萎缩侧索硬化症 (ALS):利用患者细胞和 CRISPR 揭示治疗方法
- 批准号:
10186371 - 财政年份:2021
- 资助金额:
$ 40.11万 - 项目类别:
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
用于原位检测和功能测量基因组编辑引起的不良后果的人体微组织
- 批准号:
10455604 - 财政年份:2018
- 资助金额:
$ 40.11万 - 项目类别:
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
用于原位检测和功能测量基因组编辑引起的不良后果的人体微组织
- 批准号:
10249959 - 财政年份:2018
- 资助金额:
$ 40.11万 - 项目类别:
JAX-Gladstone, SCGE Disease Models Studies Supplement
JAX-Gladstone,SCGE 疾病模型研究补充材料
- 批准号:
10620067 - 财政年份:2018
- 资助金额:
$ 40.11万 - 项目类别:
Therapeutic genome editing to treat Best disease
治疗性基因组编辑治疗最佳疾病
- 批准号:
9980913 - 财政年份:2017
- 资助金额:
$ 40.11万 - 项目类别:
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
蛋白质质量控制、心肌病、心脏毒性和人类同基因 iPSC
- 批准号:
9930312 - 财政年份:2017
- 资助金额:
$ 40.11万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer
胰腺囊性肿瘤和癌症动物模型中的转化应用
- 批准号:
9904574 - 财政年份:2018
- 资助金额:
$ 40.11万 - 项目类别:
Sleep promotion in zebrafish by hypocretin neuronal networks
下丘脑分泌素神经元网络促进斑马鱼的睡眠
- 批准号:
7506836 - 财政年份:2008
- 资助金额:
$ 40.11万 - 项目类别:
Florida International University MARC U*STAR Program
佛罗里达国际大学 MARC U*STAR 项目
- 批准号:
7426578 - 财政年份:2008
- 资助金额:
$ 40.11万 - 项目类别:
Systemic Factors that Maintain a Young Liver Phenotype
维持年轻肝脏表型的全身因素
- 批准号:
7712975 - 财政年份:2008
- 资助金额:
$ 40.11万 - 项目类别: